CPHI & PMEC China 2026
06/2026 – 06/2026
会社概要
- 正式社名: JIANGSU GTIG HUATAI CO.,LTD
- 登録国: China
- 住所: 15-16/F., Huachang Oriental Plaza, Renmin Road, Zhangjiagang City
- 従業員数: 50 - 99
説明:
Jiangsu GTIG Huatai Co., Ltd. is one of China's top 500 companies, specializing in intermediates and APIs for Sofosbuvir, Ledipasvir, Velpatasvir, Venetoclax, Obeticholic Acid, Palbociclib, Glecaprevir, Dolutegravir, Alectinib, Eribulin Mesylate, Bictegravir, Niraparib, Ribociclib, Dabigatran etexilate mesylate, Sacubitril, Vilanterol, Umeclidinium Bromide, Indacaterol, Ibrutinib, Baricitinib and Pazopanib, among others, with any patent-related products supplied for research purposes only.
事業活動
天然抽出物・生薬原料
販売代理店
医薬用化学品
販売代理店
ATC分類(解剖治療化学分類)
販売代理店
先発品原薬
販売代理店
販売市場
- Northern Europe: Denmark, Estonia, Finland, Ireland, Latvia, Lithuania, Sweden
- Southern Europe: Croatia, Greece, Italy, Malta, Portugal, Slovenia, Spain
- Eastern Europe: Bulgaria, Czech Republic
- South America: Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Falkland Islands, French Guiana, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela
当社の製品・サービス
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
証明
評価
(0)
(0)
(0)
(0)
(0)
コメント
フィルター:
並べ替え:
コメントはありません。
評価とコメントを残す